Skip to main content
Premium Trial:

Request an Annual Quote

Genome Technology s Lab Notebook: Reader Tips and Experiences: Jan 27, 2005

Following are scientists' responses to the question, "What's your top advice for designing a microarray-analysis experiment to ensure that your statistical analysis, control for error, and normalization procedures will give you an accurate end-answer?"

 

For a complete list of scientists' responses, read the November/December issue of Genome Technology, a GenomeWeb News sister publication.


"Most researchers use reference designs when doing two-color cDNA microarray experiments and only print one spot per gene. My advice to researchers using two-color arrays is to print the slides with several replicate spots per slide to provide insurance against bad spots and improve the control of error at low cost. Secondly, to use balanced, incomplete block designs (i.e. loop designs) whenever possible to reduce the cost and increase the accuracy of the results for the same number of slides. Finally, discuss the experiment with a statistician to insure that the true replication of the experiment is being done at the level of the independent biological samples."

 

James L Rosenberger
Department of
Statistics

Penn State University

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.